ADBiotech Co., Ltd.

₩1,346As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:179530Healthcare
Country South Korea
PE (Fwd) •••
TSR 7Y CAGR (17.78%)
Div yield —
ROE (23.55%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.16
PE TTM —
TSR TTM (64.72%)
Mkt cap ₩36.28B
ROIC (18.16%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,508
12.02%
10.99%
Sell 1|3|5|11|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
23.40
24.13
25.33
25.35
4.24%
11.09%
12.49%
15.21%
Revenue₩B
4.947
5.044
5.164
5.165
14.88%
12.56%
13.93%
8.21%
Peers (US$26.74M)
Cap (US$)
PE
26.04M
—
23.50M
—
Capital
TTM
5Y
10Y
Leveragex
0.428
0.243
0.209
EBIT/Intx
0.715
1.336
1.256
Own earn%
148.36
78.60
64.56
Sh yield%
43.78
43.29
43.37
Owners
Insiders/Inst%
13.91
83.00
Short interest%
3.43
SBC / revenue%
2.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
15–20
$1 testx
—
Incr. ROIC%
2